British Columbia Investment Management Corp Ionis Pharmaceuticals Inc Transaction History

British Columbia Investment Management Corp

$16.2 Billion
Q2 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$34.54 - $47.25 $751,866 - $1.03 Million	-21,768 Closed	0 $0
Q1 2021 Apr 30, 2021	SELL	$42.51 - $63.78 $27,674 - $41,520	-651 Reduced 2.9%	21,768 $979,000
Q4 2020 Feb 02, 2021	SELL	$45.3 - $60.27 $24,235 - $32,244	-535 Reduced 2.33%	22,419 $1.27 Million
Q3 2020 Nov 10, 2020	BUY	$47.45 - $62.95 $73,120 - $97,005	1,541 Added 7.2%	22,954 $1.09 Million
Q2 2020 Aug 12, 2020	BUY	$46.85 - $61.05 $318,345 - $414,834	6,795 Added 46.48%	21,413 $1.26 Million
Q1 2020 May 13, 2020	SELL	$41.6 - $63.4 $700,294 - $1.07 Million	-16,834 Reduced 53.52%	14,618 $691,000
Q4 2019 Feb 12, 2020	BUY	$53.85 - $65.27 $711,466 - $862,347	13,212 Added 72.43%	31,452 $1.9 Million
Q3 2019 Nov 14, 2019	SELL	$59.06 - $72.15 $425,940 - $520,345	-7,212 Reduced 28.34%	18,240 $1.09 Million
Q2 2019 Aug 12, 2019	BUY	$62.09 - $86.14 $1.58 Million - $2.19 Million	25,452 New	25,452 $1.64 Million

Others Institutions Holding IONS

# of Institutions

389

Shares Held

125M

Call Options Held

2.25M

Put Options Held

510K

Vanguard Group Inc Valley Forge, PA

13.8M
Shares

$550 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

12.6M
Shares

$502 Million
0.38% of portfolio
Black Rock Inc. New York, NY

10.3M
Shares

$410 Million
0.01% of portfolio
Bellevue Group Ag Kuesnacht, V8

8.26M
Shares

$328 Million
6.59% of portfolio
Wellington Management Group LLP Boston, MA

6.57M
Shares

$261 Million
0.06% of portfolio

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Account